#Product Trends
SCHILLER launches the medilogFD Holter ECG device
SCHILLER is proud to announce the launch of the medilogFD, the 12-lead Holter ECG for a spatial heart health analysis. Discover the high-end features of this technical masterpiece.
medilogFD is SCHILLER's 12-lead Holter ECG for a spatial heart health analysis. It allows assessing the full spectrum of cardiac ECG conditions. medilogFD instantly detects atrial fibrillation/atrial flutter based on a true P-wave analysis. The optional SpO2 sensor provides additional respiratory information.
This technology enables a comprehensive analysis
Physicians, cardiologists and electrophysiologists find great value in industry-leading technology: Regional assessment of myocardial ischemia. Distinguish anterior, septal, lateral, inferior region in the dynamic setting of everyday life, identify the origin of ectopic beats, whether they are from the left or right ventricle, superior in identifying abnormal heartbeats that start in the right or left atrium.
Made to suppress artifacts
The medilogFD Holter offers a very high sampling frequency of 128,000 Hz on 12 channels in resting ECG quality. This enables real-time analysis of the P waves, targeted suppression of artifacts and motion detection, so that the evaluation can be accelerated.
Holistic approach and up to 5 days of monitoring
Instantaneous detection of atrial fibrillation onset, analysis of respiratory episodes, and high-resolution HRV are just some of the exceptional features of the medilogFD.
The high-quality internal battery is recharged via USB or wirelessly on an optional charging station. Moreover, easily available standard AAA batteries can be used. This allows patients to be screened for up to five days on a single charge.
Seamlessly complements the medilog portfolio
medilogFD is the perfect complement to the medilog products medilogAR (3-channel Holter, with up to 14 days runtime) and medilog DARWIN2 (high-end software for ECG analysis).
